Clinical Research
Along with normal clinical service, wide range of clinical trials also provided in our center
We are actively recruiting patient to participate in the following clinical trials
Please send referral letter to medicaloncology@hku.hk if interested
Other Solid Tumor
Protocol Number
Protocol Title
Experimental agent
Principle Investigator
STARTRK-2
An Open-Label, Multicenter, Global Phase2 Basket Study of Entrectinib for the treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
Entrectinib
IMMU-132-11
A Phase 2 Open-Label Study of Sacituzumab Govitecan (IMMU-132) in Subjects With Metastatic Solid Tumors
Sacituzumab Govitecan-hziy (SG)
TIDENT-1
(TPX-0005-01)
Phase 2 Study
NTRK1/2/3-/ROS-1/ALK-rearranged solid tumors
Repotrectinib
BA3021-001
A Phase 1/2 Safety and Efficacy Dose Escalation / Dose Expansion Study of a CAB-ROR2-ADC, Alone and in Combination With a PD-1 Inhibitor, in Patients With Advanced Solid Tumors (Ph1) and Melanoma and NSCLC Patients (Ph2)
BA3021
VS
BA3021 + PD-1 inhibitor